Biogen Inc's Suppliers recorded an increase in sales by 3.33 % year on year in Q1 2026, from the previous quarter, sales fell by -3.13 %, Biogen Inc recorded an increase in cost of sales by 5.04 % year on year, sequentially cost of sales grew by 33.4 % in Q1.
Biogen Inc's Suppliers recorded an increase in sales by 3.33 % year on year in Q1 2026, from the previous quarter, sales fell by -3.13 %, Biogen Inc recorded increase in cost of sales by 5.04 % year on year, sequentially cost of sales grew by 33.4 % in Q1.
The company sources raw materials, delivery devices including syringes and auto-injectors, and other supplies from multiple third-party suppliers and manufacturers in quantities sufficient to meet its requirements. It maintains supply continuity through inventory management and dual sourcing when appropriate. These third-party providers are subject to routine current Good Manufacturing Practice (cGMP) inspections by the FDA or equivalent regulatory agencies and are evaluated and certified by the company's quality management group.
Biogen Inc's Comment on Supply Chain
The company sources raw materials, delivery devices including syringes and auto-injectors, and other supplies from multiple third-party suppliers and manufacturers in quantities sufficient to meet its requirements. It maintains supply continuity through inventory management and dual sourcing when appropriate. These third-party providers are subject to routine current Good Manufacturing Practice (cGMP) inspections by the FDA or equivalent regulatory agencies and are evaluated and certified by the company's quality management group.
BIIB's Suppliers Net Income grew by
BIIB's Suppliers Net margin grew in Q1 to
133.3 %
8.96 %
BIIB's Suppliers Net Income grew by 133.3 %
BIIB's Suppliers Net margin grew in Q1 to 8.96 %
Biogen Inc's Suppliers Sales Growth
in Q1 2026 by Industry
Sources:
Biogen Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Biogen Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
1.62 % 